Cargando…
Probio-X Relieves Symptoms of Hyperlipidemia by Regulating Patients’ Gut Microbiome, Blood Lipid Metabolism, and Lifestyle Habits
Hyperlipidemia is a key risk factor for cardiovascular disease, and it is associated with lipid metabolic disorders and gut microbiota dysbiosis. Here, we aimed to investigate the beneficial effects of 3-month intake of a mixed probiotic formulation in hyperlipidemic patients (n = 27 and 29 in place...
Autores principales: | Wang, Huan, Ma, Cuicui, Li, Yan, Zhang, Lei, A, lima, Yang, Chengcong, Zhao, Feiyan, Han, Haifeng, Shang, Dongyang, Yang, Fan, Zhang, Yuying, Zhang, Heping, Sun, Zhihong, Guo, Ruifang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10269629/ https://www.ncbi.nlm.nih.gov/pubmed/37022264 http://dx.doi.org/10.1128/spectrum.04440-22 |
Ejemplares similares
-
Change in the Gut Microbiome and Immunity by Lacticaseibacillus
rhamnosus Probio-M9
por: Zhang, Meng, et al.
Publicado: (2023) -
Lacticaseibacillus rhamnosus Probio-M9 extends the lifespan of Caenorhabditis elegans
por: Zhang, Juntao, et al.
Publicado: (2022) -
Bifidobacterium animalis subsp. lactis Probio-M8 undergoes host adaptive evolution by glcU mutation and translocates to the infant’s gut via oral-/entero-mammary routes through lactation
por: Zhong, Zhi, et al.
Publicado: (2022) -
Plasma Purification Treatment Relieves the Damage of Hyperlipidemia to PBMCs
por: Zhang, Xiao Meng, et al.
Publicado: (2021) -
Bifidobacterium lactis Probio-M8 Adjuvant Treatment Confers Added Benefits to Patients with Coronary Artery Disease via Target Modulation of the Gut-Heart/-Brain Axes
por: Sun, Baoqing, et al.
Publicado: (2022)